Summary
Datamonitor's King Pharmaceuticals, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
King Pharmaceuticals is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The company primarily operates in the US and Puerto Rico. The company is headquartered in Bristol, Tennessee and employs more than 2,000 people. The company recorded revenues of $2,136.9 million during the fiscal year ended December 2007, an increase of 7.5% over 2006. The increase was mainly due to the acquisition of Avinza in February 2007 and an increase in gross sales of the company's Meridian Auto-Injector segment. The operating profit of the company was $227.5 million during fiscal year 2007, as compared to an operating profit of $402.5 million in 2006. The net profit was $182.9 million in fiscal year 2007, compared to a net profit of $288.9 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available.
|
